FASLG and melanoma: The plasma of melanoma patients harbor increased levels of exosomes that contain immunosuppressive proteins such as Fas ligand (FasL) and transforming growth factor beta (TGF-β), melanoma-associated antigens (MAAs), and oncoproteins, including Myc [18,47,51,52].